reatment Standards and Outcomes of Patients With ER/PR Positive HER2-negative Metastatic Breast Cancer

  • STATUS
    Recruiting
  • participants needed
    300
  • sponsor
    Hellenic Society of Medical Oncology
Updated on 19 February 2024
cancer
breast cancer
stage iv breast cancer
HER2

Summary

To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece

Description

  • To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece
    • To evaluate the outcome of patients per treatment line (objective response, progression free survival, time to disease progression per line of therapy), overall survival
    • To record adverse events per line of therapy
    • To recording of the causes of treatment discontinuation per line of therapy

Details
Condition Metastatic Breast Cancer
Age 18-100 years
Clinical Study IdentifierNCT04247035
SponsorHellenic Society of Medical Oncology
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Women with histological confirmed ER/PR positive, HER2-negative MBC
Age >18 years old
Patients initiating first or second line therapy for ER/PR positive, HER2-negative MBC
Adequate hematologic, renal and hepatic function
Signed informed consent (ICF)

Exclusion Criteria

Active malignancy other than MBC
Active infection
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.